Improving HPV Vaccination Coverage: Current Issues, Future Prospects and Strategies
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Papillomavirus Vaccines".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 6966
Special Issue Editor
Interests: epidemiology; cervical cancer; prevention; vaccines; vaccination coverage; vaccination schedule; burden of disease; risk factors; cancers; infectious disease; evidence-based medicine; meta-analysis
Special Issue Information
Dear Colleagues,
Globally, cervical cancer ranks as the fourth most common cancer and fourth leading cause of cancer death in women. According to the International Agency for Research on Cancer, Human papillomavirus (HPV) is considered carcinogenic to humans, particularly for cervix uteri.
The first HPV vaccine was approved in 2006, and the latest data show a significant overall reduction in cervical cancer incidence in the cohort of vaccinated adolescents worldwide. Countries are reporting a 65–97% reduction in the occurrence of cervical cancer in the population of vaccinated women.
But disparities in cervical cancer burden will likely widen with differences in HPV vaccination coverage. According to the latest WHO data, globally in 2022 the HPV vaccination program coverage in females was 21% with the first dose and 15% with the last dose, while in males the coverage was 6% and 5%, respectively, with coverage varying more than 20-fold between WHO regions. In response to this, WHO updated recommendations for the HPV vaccination schedule.
Improving HPV vaccination coverage is essential in reducing the burden of HPV-related cancers and health inequities. The COVID-19 pandemic has significantly disrupted HPV vaccination worldwide. This Special Issue is focused on current issues, future prospects and strategies aimed at improving HPV vaccination coverage.
Dr. Irena Ilic
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HPV vaccine
- HPV-related cancers
- vaccination
- vaccine coverage
- vaccine acceptance
- vaccine hesitancy
- vaccines knowledge, attitudes and practice
- immunity
- prevention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.